|
1. Cannon JT, Prieto GJ, Lee A,Liebeskind JC. Evidence for opioid and non-opioid forms of stimulation –produced analgesia in the rat. Brain Res. 1982; 243:2:315-21. doi: 10.1016/0006-8993:8290255-4 2. Mason P. Medullary circuits for nociceptive modulation. Curr Opin Neurobiol. 2012; 22:4:640- doi: 10.1016/j.conb.2012.03.008. 3. Pozo-Rosich P, Storer RJ, Charbit AR, Goadsby PJ. Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons. Cephalalgia: IHS. 2015; 35:14:1298-307. doi:10.1177/0333102415576723. 4. Huang Y, Brodda-Jansen G, Lundeberg T, Yu LC. Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone. Brain. 2000; 873:1:54-9.doi: 10.1016/s0006-8993(00)02473-2. 5. Gorn AH, Lin HY, Yamin M, Auron PE, Flannery MR, Tapp DR, et al. Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. JCI. 1992; 90:5:1726-35. doi: 10.1172/JCI116046. 6. Pecile A, Guidobono F, Netti C, Sibilia V, Biella G, Braga PC. Calcitonin gene-related peptide: antinociceptive activity in rats, comparison with calcitonin. Regul Pept. 1987;18:3-4:189-99. doi: 10.1016/0167-0115(87)90007-3. 7. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1(Suppl 1):S62-S9. doi: 10.2337/dc10-S062 8. Balali Dehkordi Sh, Sajedianfard J, Owji AA. The effect of intra-cerebroventricular injection of insulin on the levels of monoamines on the raphe magnus nucleus of non-diabetic and short-term diabetic rats in the formalin test. Iran J Basic Med Sci. 2019; 22:8: 915–921. doi: 10.22038/ijbms.2019.35580.8485. 9. Walker CS, Conner AC, Poyner DR, Hay DL. Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends Pharmacol Sci. 2010; 31:10:476-83. doi: 10.1016/j.tips.2010.06.006 . 10. Yu L-C, Weng X-H, Wang J-W, Lundeberg T. Involvement of calcitonin gene-related peptide and its receptor in anti-nociception in the periaqueductal grey of rats. Neurosci Lett. 2003;349:1:1-4. doi: 10.1016/S0304-3940(03)00273-8. 11. Eftekhari S, Edvinsson L. Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC Neuroscience. 2011;4:8:43-52. doi: 10.1186/1471-2202-12-112. 12. Poyner DR. Calcitonin gene-related peptide: multiple actions, multiple receptors. Pharmacol Ther. 1992; 56:1:23-51. doi: 10.1016/0163-7258(92)90036-y . 13. Harmann PA, Chung K, Briner RP, Westlund KN, Carlton SM. Calcitonin gene-related peptide (CGRP) in the human spinal cord: a light and electron microscopic analysis. J. Comp. Neurol. 1988; 269:3:371-80. doi: 10.1002/cne.902690305. 14. Rahimi K, Sajedianfard J, Owji A.A. The effect of intracerebroventricular injection of CGRP on pain behavioral responses and monoamines concentrations in the periaqueductal gray area in rat. IJBMS. 2018:21:4:395-399. doi: 10.22038/IJBMS.2018.26384.6467. 15. Gibson SJ, Polak JM, Bloom SR, Sabate IM, Mulderry PM, Ghatei MA, McGregor GP, Morrison JF, Kelly JS, Evans RM. Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. JNeurosci. 1984;4:12::3101-1. doi: 10.1523/JNEUROSCI.04-12-03101.1984. 16. Iyengar S, Ossipov MH, Johnson KW. The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. Pain. 2017;158:4:543-559. doi: 10.1097/j.pain.0000000000000831 17. Bhatt DK, Gupta S, Ploug KB, Jansen-Olesen I, Olesen J. mRNA distribution of CGRP and its receptor components in the trigeminovascular system and other pain related structures in rat brain, and effect of intracerebroventricular administration of CGRP on Fos expression in the TNC. Neurosci Lett. 2014; 24 :559:99-104. doi: 10.1016/j.neulet.2013.11.057 . 18. McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad. Sci. U.S.A. 2007; 104:76: 13525–13530. doi: 10.1073/pnas.0705924104 . 19. Macpherson LJ, Xiao B, Kwan KY, Petrus MJ, Dubin AE, et al. An ion channel essential for sensing chemical damage. J Neurosci. 2007; 27: 11412–11415. doi: 10.1523/JNEUROSCI.3600-07. 20. White S, Marquez de Prado B, Russo A.F. Hammond D.L. Heat Hyperalgesia and Mechanical Hypersensitivity Induced by Calcitonin Gene-Related Peptide in a Mouse Model of Neurofibromatosis. PLos One. 2014;9:9:1-10. doi: 10.1371/journal.pone.0106767. 21. Spampinato S, Candeletti S, Cavicchini E, Romualdi P, Speroni E, Ferri S. Antinociceptive activity of salmon calcitonin injected intrathecally in the rat. Neurosci Lett. 1984;45(2):135-9. doi.org/10.1016/0304-3940(84)90088-0. 22. Zou Y, Xu F, Tang Z, Zhong T, Cao J, Guo Q, et al. Distinct calcitonin gene-related peptide expression pattern in primary afferents contribute to different neuropathic symptoms following chronic constriction or crush injuries to the rat sciatic nerve. Mol pain. 2016;12:1744806916681566. doi: 10.1177/1744806916681566. 23. Daneshyar S, Gharakhanlou R, Nikooie R, Forutan Y. The effect of high-fat diet and streptozotocin-induced diabetes and endurance training on plasma levels of calcitonin gene-related peptide and lactate in rats. CanJDiabetes. 2014;38: 461-465. doi: 10.1016/j.jcjd.2014.03.001. 24. Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes. 2015;6:3:432-44. doi: 10.4239/wjd.v6.i3.432. 25. Lee JH, McCarty R. Pain threshold in diabetic rats: effects of good versus poor diabetic control. Pain. 1992;50:2:231-6. doi. 10.1016/0304-3959(92)90167-A. 26. Li H, Song Y, Wang Z, Wu Y, Wang W, Han J. Overexpression of CGRP improves peripheral neuropathy in diabetic mice. Chinese. 2019; 35:3:250-255.
|
